Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae : 1-year survey in a French university hospital

2004 ◽  
Vol 23 (6) ◽  
pp. 456-462 ◽  
Author(s):  
C. De Champs ◽  
C. Rich ◽  
P. Chandezon ◽  
C. Chanal ◽  
D. Sirot ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Klebsiella Pneumoniae ◽  
Clinical Isolates ◽  
University Hospital ◽  
Factors Associated

scholarly journals Heterogeneity of Klebsiella pneumoniae Clinical Isolates Obtained From Stony Brook University Hospital

2015 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
Aisha Khan ◽  
Mutayyaba Adnan ◽  
Bettina Fries ◽  
Eric Spitzer ◽  
Elizabeth Diago-Navarro
Keyword(s):  
Klebsiella Pneumoniae ◽  
Clinical Isolates ◽  
University Hospital

scholarly journals Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany

2021 ◽  
Author(s):  
Roger Dumke
Keyword(s):  
Antimicrobial Resistance ◽  
Ureaplasma Urealyticum ◽  
Urogenital Tract ◽  
Molecular Methods ◽  
Clinical Isolates ◽  
University Hospital ◽  
Minimal Inhibitory Concentrations ◽  
Ureaplasma Spp

Ureaplasma urealyticum and U. parvum are mollicutes species that colonize the urogenital tract of many asymptomatic persons but are also thought to be associated with symptomatic infections. Using 170 strains isolated between 2016 and 2019 in a German university hospital, resistance was tested by a combination of commercial tests, molecular methods and determination of minimal inhibitory concentrations. Rates of resistance to macrolides, tetracyclines and fluoroquinolones were 0%, 4.1% and 7.1%, respectively.

scholarly journals The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital

2021 ◽  
Vol Volume 15 ◽  
pp. 3095-3104
Author(s):  
Worapong Nasomsong ◽  
Parnrada Nulsopapon ◽  
Dhitiwat Changpradub ◽  
Manat Pongchaidecha ◽  
Supanun Pungcharoenkijkul ◽  
...  
Keyword(s):  
Klebsiella Pneumoniae ◽  
Clinical Isolates ◽  
University Hospital ◽  
Carbapenem Resistant ◽  
Potential Use ◽  
Thai University

CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand

2010 ◽  
Vol 68 (3) ◽  
pp. 271-277 ◽  
Author(s):  
Supoj Singtohin ◽  
Aroonwadee Chanawong ◽  
Aroonlug Lulitanond ◽  
Pipat Sribenjalux ◽  
Amorn Auncharoen ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Klebsiella Pneumoniae ◽  
Clinical Isolates ◽  
University Hospital

scholarly journals Susceptibility ofKlebsiella pneumoniaeIsolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

2011 ◽  
Vol 55 (8) ◽  
pp. 3917-3921 ◽  
Author(s):  
Stephen P. Hawser ◽  
Samuel K. Bouchillon ◽  
Christine Lascols ◽  
Meredith Hackel ◽  
Daryl J. Hoban ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Klebsiella Pneumoniae ◽  
Molecular Characterization ◽  
Clinical Isolates ◽  
Extended Spectrum ◽  
Clinical Breakpoints ◽  
Abdominal Infections

ABSTRACTA total of 2,841 clinical isolates ofKlebsiella pneumoniaefrom intra-abdominal infections worldwide were collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) during 2008 and 2009. Overall, 22.4% of isolates had extended-spectrum β-lactamases (ESBLs). The most active antibiotics among the 11 tested were imipenem, amikacin, and ertapenem, though even these, like all other comparators, were less consistently active against ESBL-positive isolates than against ESBL-negative isolates. Globally, 6.5% of isolates were ertapenem resistant based on the June 2010 clinical breakpoints published by the Clinical and Laboratory Standards Institute, with MICs of ≥1 μg/ml. Molecular characterization of 43 isolates with ertapenem MICs of ≥4 μg/ml showed that they variously produced CTX-M or SHV ESBLs combined with altered impermeability and/or had KPC (n= 28), OXA-48 (n= 3), or VIM (n= 1) carbapenemases. Further monitoring of ertapenem susceptibility and molecular characterization of ertapenem-resistant isolates are needed.

Sign in / Sign up

Export Citation Format

Share Document